TipRanks
Silo Pharma (SILO)
NASDAQ:SILO
US Market
SILO
Silo Pharma
RESEARCH TOOLSreports

Silo Pharma (SILO) Income Statement

225 Followers

Silo Pharma Income Statement

Last quarter (Q2 2026), Silo Pharma's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q2, Silo Pharma's net income was $-832.83K. See Silo Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 72.10K$ 72.10K$ 72.10K$ 72.10K$ 71.26K
Gross Profit
$ -813.96K$ 66.26K$ 66.26K$ 66.26K$ 66.26K
Operating Expenses
$ 3.47M$ 4.77M$ 3.92M$ 3.69M$ 2.81M
Depreciation and Amortization
$ 11.44K$ 6.18K$ 0.00$ 0.00$ 0.00
EBITDA
$ -4.18M$ -4.38M$ -3.63M$ -3.91M$ 4.19M
Operating Income
$ -4.28M$ -4.71M$ -3.86M$ -3.63M$ -2.74M
Other Income/Expenses
$ 52.96K$ 312.81K$ 224.51K$ -279.73K$ 6.93M
Pretax Income
$ -4.23M$ -4.39M$ -3.63M$ -3.91M$ 4.18M
Net Income
$ -4.23M$ -4.39M$ -3.70M$ -3.91M$ 3.90M
Per Share Metrics
Basic EPS
$ -7.50$ -17.85$ -18.00$ -25.65$ 19.80
Diluted EPS
$ -7.50$ -17.85$ -18.00$ -25.65$ 19.50
Weighted Average Shares Outstanding
 558.82K 245.36K 205.32K 152.28K 126.49K
Weighted Average Shares Outstanding (Diluted)
 558.82K 245.36K 205.32K 152.28K 127.90K
Currency in USD

Silo Pharma Earnings and Revenue History